Article
Antihypertensive therapy in preeclampsia is not modulated by VEGF polymorphisms.
Archives of gynecology and obstetrics - 1 Apr 2015
Sandrim Valeria C, Palei Ana C T, Eleuterio Nibia, Tanus-Santos Jose E, Cavalli Ricardo C
Abstract excerpt
INTRODUCTION: Vascular endothelial growth factor (VEGF) is relevant for healthy pregnancy, and abnormalities in VEGF functions have been associated with hypertensive disorders of pregnancy. Our group recently demonstrated that VEGF genetic polymorphisms affect the susceptibility to preeclampsia (PE). OBJECTIVE: Therefore, in this study our aim is to examine whether VEGF polymorphisms affect the antihypertensive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
